Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides

Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides

US Patent 10624908 · Granted Apr 21, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused fibre couplers, and apparatuses and methods for the manufacture and use th2022
Water contaminant measurement system and methods for measuring concentration lev2022
System and method for synthesizing polymeric capsules for water softening2021
Abrasion-resistant rubber roll cover with polyurethane coating2019
Strains of the genus Lactobacillus and use thereof2018
Strains of the genus Lactobacillus and use thereof2018
Strains of the genus Lactobacillus and use thereof2018
Stable pantetheine derivatives for the treatment of pantothenate kinase associat2018
Stable pantetheine derivatives for the treatment of pantothenate kinase associat2018
Stable pantetheine derivatives for the treatment of pantothenate kinase associat2018
Stable pantetheine derivatives for the treatment of pantothenate kinase associat2018
Co-cultivation of propionibacterium and yeast2018